日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors

通过将 BCL-2 抑制剂维奈托克转化为多药理双重 BCL-2/HDAC1 抑制剂和双重 BCL-2/HDAC6 抑制剂来增强其抗白血病活性

Alexandria M Chan ,Christian Eberly ,Brandon Drennen ,Christopher C Goodis ,Zoe Wuyts ,Curt I Civin ,Steven Fletcher

Multimodal nanoparticle-containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation

含有多模式纳米颗粒的修饰型辛酰苯胺异羟肟酸聚合物缀合物可减轻严重炎症中的免疫功能障碍

Nhu Truong ,Andrea L Cottingham ,Shruti Dharmaraj ,Jacob R Shaw ,Jackline Joy Martin Lasola ,Christopher C Goodis ,Steven Fletcher ,Ryan M Pearson

The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth

双价溴结构域抑制剂 MT-1 可抑制前列腺癌生长

Sanjeev Shukla, Carlos Riveros, Mohammed Al-Toubat, Jonathan Chardon-Robles, Teruko Osumi, Samuel Serrano, Adam M Kase, Joachim L Petit, Nathalie Meurice, Justyna Gleba, John A Copland 3rd, Jay Chauhan, Steven Fletcher, K C Balaji

The ERK2-DBP domain opposes pathogenesis of a mouse JAK2V617F-driven myeloproliferative neoplasm

ERK2-DBP 结构域抑制小鼠 JAK2V617F 驱动的骨髓增生性肿瘤的发病机制

Yong Zhang, Billy Truong, Shawn P Fahl, Esteban Martinez, Kathy Q Cai, Essel D Al-Saleem, Yulan Gong, Dan A Liebermann, Jonathan Soboloff, Roland Dunbrack, Ross L Levine, Steven Fletcher, Dietmar Kappes, Stephen M Sykes, Paul Shapiro, David L Wiest

Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge

改性辛酰苯胺异羟肟酸可降低脂多糖炎症刺激下药物相关的免疫细胞死亡和器官损伤

Nhu Truong ,Christopher C Goodis ,Andrea L Cottingham ,Jacob R Shaw ,Steven Fletcher ,Ryan M Pearson

Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways

放射性核素刺激动态疗法正交靶向破骨细胞和骨髓瘤细胞诱导多维细胞死亡途径

Alexander Zheleznyak, Matthew Mixdorf, Lynne Marsala, Julie Prior, Xiaoxia Yang, Grace Cui, Baogang Xu, Steven Fletcher, Francesca Fontana, Gregory Lanza, Samuel Achilefu

Shared and distinct mechanisms of skeletal muscle atrophy: A narrative review

骨骼肌萎缩的共同机制和独特机制:一篇叙述性综述

Wilburn, Dylan; Ismaeel, Ahmed; Machek, Steven; Fletcher, Emma; Koutakis, Panagiotis

VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival

VLA4 靶向纳米粒子劫持细胞粘附介导的耐药性,以靶向难治性骨髓瘤细胞并延长生存期

Francesca Fontana, Michael J Scott, John S Allen, Xiaoxia Yang, Grace Cui, Dipanjan Pan, Noriko Yanaba, Mark A Fiala, Julie O'Neal, Anne H Schmieder-Atteberry, Julie Ritchey, Michael Rettig, Kathleen Simons, Steven Fletcher, Ravi Vij, John F DiPersio, Gregory M Lanza

Mechanistic Analysis of an Extracellular Signal-Regulated Kinase 2-Interacting Compound that Inhibits Mutant BRAF-Expressing Melanoma Cells by Inducing Oxidative Stress

通过诱导氧化应激抑制突变型 BRAF 表达黑色素瘤细胞的细胞外信号调节激酶 2 相互作用化合物的机制分析

Ramon Martinez 3rd, Weiliang Huang, Ramin Samadani, Bryan Mackowiak, Garrick Centola, Lijia Chen, Ivie L Conlon, Kellie Hom, Maureen A Kane, Steven Fletcher, Paul Shapiro

Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer

c-myc 抑制剂的纳米疗法靶向乳腺癌中的促肿瘤巨噬细胞并保留抗肿瘤巨噬细胞

Alison K Esser, Michael H Ross, Francesca Fontana, Xinming Su, Ariel Gabay, Gregory C Fox, Yalin Xu, Jingyu Xiang, Anne H Schmieder, Xiaoxia Yang, Grace Cui, Michael Scott, Samuel Achilefu, Jay Chauhan, Steven Fletcher, Gregory M Lanza, Katherine N Weilbaecher